person

Davide L.

Country
Italy
Department
U.O.C. Endocrinologia e Diabetologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
2
Sites with multiple studies

Has run more than one trial at 2 of 30 partner sites.

Specializations

Diabetes Management

This investigator specializes in the treatment of Type 2 diabetes mellitus, with particular focus on innovative therapeutic approaches using SGLT2 inhibitors in elderly populations. Their research explores optimal glycemic control strategies while maintaining patient safety.

  • Elderly diabetic patient care
  • Glycemic control optimization
  • Hypoglycemia prevention

The investigator's work contributes to understanding individualized treatment approaches in diabetes management.

Cardiovascular Outcomes

The investigator studies the relationship between diabetes treatments and cardiovascular health, particularly examining novel therapeutic agents like tirzepatide. Their research focuses on major cardiovascular events in diabetic patients with high cardiovascular risk.

  • Cardiovascular risk assessment
  • Comparative treatment efficacy
  • Long-term cardiovascular outcomes

Their work encompasses evaluation of cardiovascular safety profiles in diabetes medications.

Diabetic Complications

The investigator focuses on advanced treatments for diabetic foot ulcers, exploring novel therapeutic compounds including neurotrophins mimetics. Their research evaluates innovative approaches to wound healing in diabetes.

  • Wound healing therapies
  • Standard of care enhancement
  • Novel treatment development

Their research aims to improve outcomes in diabetic wound management through innovative therapeutic approaches.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.